Table 1 Demographic data of the patients receiving unilateral TKA
Item | Group A (n = 2687) | Group B (n = 3761) | P value |
|---|---|---|---|
Age [year, M (Q1, Q3)] | 67 (61, 72) | 67 (61, 73) | 0.456 |
Gender [n(%)] | 0.412 | ||
Male | 582 (21.66) | 847 (22.52) | |
Female | 2105 (78.34) | 2914 (77.48) | |
BMI [kg/m2, M (Q1, Q3)] | 24.98 (22.60, 27.89) | 25.39 (23.01, 27.78) | 0.091 |
Hypertension [n(%)] | 646 (24.04) | 907 (24.12) | 0.945 |
Diabetes [n(%)] | 187 (6.96) | 297 (7.90) | 0.159 |
CHD [n(%)] | 91 (3.38) | 148 (3.94) | 0.250 |
ASA class [n(%)] | 0.281 | ||
1 | 860 (32.01) | 1232 (32.76) | |
2 | 1606 (59.77) | 2175 (57.83) | |
3 | 215 (8.00) | 343 (9.12) | |
4 | 6 (0.22) | 11 (0.29) | |
Anesthesia [n(%)] | 0.451 | ||
General anesthesia | 1762 (65.57) | 2418 (64.29) | |
Spinal anesthesia | 175 (6.51) | 272 (7.23) | |
Epidural anesthesia | 117 (4.35) | 150 (3.99) | |
CSEA | 633 (23.56) | 921 (24.49) | |
Drainage [n(%)] | 1852 (68.92) | 2549 (67.77) | 0.328 |
Tourniquet [n(%)] | 2045 (76.11) | 2798 (74.40) | 0.117 |
Anticoagulation [n(%)] | 0.283 | ||
Enoxaparin | 1256 (46.74) | 1431 (38.05) | |
Rivaroxaban | 1809 (67.32) | 1952 (51.90) | |
ROM (°, Mean ± SD) | 84.88 ± 15.15 | 85.08 ± 14.88 | 0.592 |